Ignite Creation Date:
2025-12-24 @ 9:59 PM
Ignite Modification Date:
2026-02-20 @ 1:33 PM
Study NCT ID:
NCT01380132
Status:
COMPLETED
Last Update Posted:
2011-06-28
First Post:
2011-06-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Anorectal Application of Dx-gel for Treatment of Anal Incontinence
Sponsor:
Uppsala University Hospital
Organization:
Study Overview
Official Title:
Safety and Efficacy of Anorectal Application of Dx-gel for Treatment of Anal Incontinence
Status:
COMPLETED
Status Verified Date:
2010-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether anorectal application of Nasha Dx is safe and effective for treatment of anal incontinence.
Detailed Description:
Patients not fully improved after 1:st injection were offered reinjection after 4-6 weeks.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 03 464 | OTHER | EPN Uppsala | View |